Also trades as: KTTA (NASDAQ) · $vol 0M
KTTAW NASDAQ
Pasithea Therapeutics Corp.
1W: +3.7%
1M: -60.6%
3M: -62.7%
YTD: -80.7%
1Y: -88.8%
$0.00
-0.00 (-6.67%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.0M
52W Range0.0025-0.0122
Volume383
Avg Volume11,440
Beta0.29
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTiago Reis Marques
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2021-09-15
Websitepasithea.com
1111 Lincoln Road
Miami Beach, FL 33139
US
Miami Beach, FL 33139
US
702-514-4174
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. is a biotechnology firm dedicated to exploring and developing therapies for various psychiatric and neurological conditions. Beyond its research endeavors, the company intends to establish clinics specializing in the treatment of depression. At these facilities, certified pharmacists will administer intravenous ketamine infusions, and the firm will also extend business support services for these operations. Founded in 2020, Pasithea Therapeutics Corp. maintains its corporate headquarters in Miami Beach, Florida.
Latest News
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
Pasithea Therapeutics Announces Exhibit at Children's Tumor Foundation 2026 NF Conference
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Krishnan Kartik | 0 | — | 2026-05-01 | |
| STEINMAN LAWRENCE | A-Award | 152,783 | $0.84 | 2026-05-01 |
| Dumesnil Simon | A-Award | 152,783 | $0.84 | 2026-05-01 |
| Leahy Emer | A-Award | 152,783 | $0.84 | 2026-05-01 |
| Novak Alfred J | A-Award | 152,783 | $0.84 | 2026-05-01 |